- Filed
- Sep 9, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Sep 3, 2024 | 92.26M sh |
| Cash And Equivalents | Q2 2024 · Jan 31, 2024 | $178.32M |
| Cash And Equivalents | Q2 2024 · Jul 31, 2023 | $224.74M |
| Current Liabilities | Q2 2024 · Jan 31, 2024 | $994.21M |
| Current Liabilities | Q2 2024 · Jul 31, 2023 | $957.48M |
| Total Liabilities | Q2 2024 · Jan 31, 2024 | $2B |
| Total Liabilities | Q2 2024 · Jul 31, 2023 | $2B |
| Current Assets | Q2 2024 · Jan 31, 2024 | $1.28B |
| Current Assets | Q2 2024 · Jul 31, 2023 | $1.37B |
| Total Assets | Q2 2024 · Jan 31, 2024 | $4.11B |
| Total Assets | Q2 2024 · Jul 31, 2023 | $3.97B |
| Shares Diluted | Q2 2024 · Jul 31, 2023 | 94.23M sh |
| Shares Diluted | Q2 2024 · Jul 31, 2023 | 94.03M sh |
| Stock Repurchased | Q2 2024 · Jul 31, 2023 | $0 |
| Capex | Q2 2024 · Jul 31, 2023 | $78.52M |
| Operating Cash Flow | Q2 2024 · Jul 31, 2023 | $211.25M |
| Stockholders Equity | Q2 2024 · Jul 31, 2023 | $1.97B |
| Stockholders Equity | Q2 2024 · Apr 30, 2023 | $1.85B |
| Stockholders Equity | Q2 2024 · Jan 31, 2023 | $1.79B |
| Eps Diluted | Q2 2024 · Jul 31, 2023 | $1.10 |
| Eps Diluted | Q2 2024 · Jul 31, 2023 | $1.67 |
| Eps Basic | Q2 2024 · Jul 31, 2023 | $1.12 |
| Eps Basic | Q2 2024 · Jul 31, 2023 | $1.69 |
| Sga Expense | Q2 2024 · Jul 31, 2023 | $323.48M |
| Sga Expense | Q2 2024 · Jul 31, 2023 | $623.33M |
| Net Income | Q2 2024 · Jul 31, 2023 | $104.09M |
| Net Income | Q2 2024 · Jul 31, 2023 | $156.91M |
| Operating Income | Q2 2024 · Jul 31, 2023 | $132.1M |
| Operating Income | Q2 2024 · Jul 31, 2023 | $203.48M |
| Gross Profit | Q2 2024 · Jul 31, 2023 | $455.58M |
| Gross Profit | Q2 2024 · Jul 31, 2023 | $826.81M |
| Cost Of Revenue | Q2 2024 · Jul 31, 2023 | $816.61M |
| Cost Of Revenue | Q2 2024 · Jul 31, 2023 | $1.56B |
| Revenue | Q2 2024 · Jul 31, 2023 | $1.27B |
| Revenue | Q2 2024 · Jul 31, 2023 | $2.39B |